# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch - Amoxicillin Clavulanate Potassium Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/f23a7fa9-6b75-4aca-8b0c-935936131f62/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch published July 28, 2022. Drug: Amoxicillin Clavulanate Potassium Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch
- Publication Date: 2022-07-28
- Drug Name: Amoxicillin Clavulanate Potassium Tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/3bc2a5d2-1c14-4c56-9122-3363685b4c1d/
